Literature DB >> 2665415

Repair of bone defects with marrow cells and porous ceramic. Experiments in rats.

H Ohgushi1, V M Goldberg, A I Caplan.   

Abstract

We studied the role of bone-marrow reconstituted porous ceramics in enhancing healing of a 5-mm femoral diaphyseal defect fixed with a rigid polyethylene plate in rats. Osseous repair was evaluated by histologic scoring. When blocks of porous calcium phosphate ceramics alone were introduced into the defects, most cases showed fibrous tissue interposition at the host bone-ceramic junction 1 month after implantation, and only four of 12 defects developed osseous or osteochondral union at both the proximal and distal junctions 2 months after surgery. However, when the ceramic was combined with syngeneic viable marrow cells, new bone formation occurred in isolated pore regions of the ceramic at 1 month, and extensive bone formation was seen in most pore regions 2 months after implantation. Out of 12 implants, complete bone union was seen in eight, and one showed osseous or osteochondral union at both junctions 2 months after surgery. Our results indicated that composite grafts of porous calcium phosphate ceramics and marrow cells may be clinically applicable to enhance osteogenesis and osteoconduction.

Entities:  

Mesh:

Year:  1989        PMID: 2665415     DOI: 10.3109/17453678909149289

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  41 in total

1.  Interactions of human osteoprogenitors with porous ceramic following diffusion chamber implantation in a xenogeneic host.

Authors:  R Gundle; C J Joyner; J T Triffitt
Journal:  J Mater Sci Mater Med       Date:  1997-08       Impact factor: 3.896

2.  Regenerative medicine: Are calcium phosphate ceramics 'smart' biomaterials?

Authors:  Barbara D Boyan; Zvi Schwartz
Journal:  Nat Rev Rheumatol       Date:  2011-01       Impact factor: 20.543

3.  Selective retention of bone marrow-derived cells to enhance spinal fusion.

Authors:  George F Muschler; Yoichi Matsukura; Hironori Nitto; Cynthia A Boehm; Antonio D Valdevit; Helen E Kambic; William J Davros; Kirk A Easley; Kimerly A Powell
Journal:  Clin Orthop Relat Res       Date:  2005-03       Impact factor: 4.176

4.  Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy.

Authors:  R Binato; T de Souza Fernandez; C Lazzarotto-Silva; B Du Rocher; A Mencalha; L Pizzatti; L F Bouzas; E Abdelhay
Journal:  Cell Prolif       Date:  2012-11-16       Impact factor: 6.831

5.  Role of stromal cell-derived factor-1 expression in the injured mouse auditory nerve.

Authors:  Lauren A Kilpatrick; Juhong Zhu; Fu-Shing Lee; Hainan Lang
Journal:  Otolaryngol Head Neck Surg       Date:  2011-09-23       Impact factor: 3.497

6.  The effect of fresh bone marrow cells on reconstruction of mouse calvarial defect combined with calvarial osteoprogenitor cells and collagen-apatite scaffold.

Authors:  Xiaohua Yu; Liping Wang; Fei Peng; Xi Jiang; Zengmin Xia; Jianping Huang; David Rowe; Mei Wei
Journal:  J Tissue Eng Regen Med       Date:  2012-03-31       Impact factor: 3.963

7.  [Allogenic transplantation of human mesenchymal stem cells for tissue engineering purposes: an in vitro study].

Authors:  P Niemeyer; A Seckinger; H G Simank; P Kasten; N Südkamp; U Krause
Journal:  Orthopade       Date:  2004-12       Impact factor: 1.087

Review 8.  Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance.

Authors:  Mirjam Fröhlich; Warren L Grayson; Leo Q Wan; Darja Marolt; Matej Drobnic; Gordana Vunjak-Novakovic
Journal:  Curr Stem Cell Res Ther       Date:  2008-12       Impact factor: 3.828

9.  Human bone marrow stromal cells express an osteoblastic phenotype in culture.

Authors:  J Vilamitjana-Amedee; R Bareille; F Rouais; A I Caplan; M F Harmand
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-09       Impact factor: 2.416

10.  Hydroxyapatite-glass composite as a bone substitute in large metaphyseal cavities in rabbits.

Authors:  E A Suominen; A J Aho; J Juhanoja; A Yli-Urpo
Journal:  Int Orthop       Date:  1995       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.